Hela-GFP stable cells Puromycin
Order now: dominika@ksiazkiwnauce.pl
SH-SY5Y / GFP (Puromycin) stable cell line |
|||
SC042 | GenTarget | 2 x 106 cell/ml x 1ml | 1017.6 EUR |
Description: GFP expression stable cell line in SH-SY5Y cells with Puromycin resistance |
|||
Luciferase(firefly) Hela Report Cell Line(Puromycin) |
|||
ABC-RC147D | AcceGen | 1 vial | Ask for price |
Description: Transformed from Hela cells by lentiviral system with sequence verified firefly luciferase gene. Luciferase was expressed under CMV promoter, A Puromycin antibiotic marker was expressed under Rsv promoter. The cell constitutively express Luciferase enzyme. |
|||
ZR-75-1 / GFP (Puromycin) Stable Cell Line |
|||
SC051-G | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: GFP expression stable cell line in ZR-75-1 cells with Puromycin resistance |
|||
Luciferase-2A-RFP Report Cell Line(Puromycin)-Hela |
|||
ABC-RC155D | AcceGen | 1 vial | Ask for price |
Description: Transformed from Hela cells by lentiviral system with sequence verified firefly luciferase gene II and RFP. The Luciferase and RFP was co-expressed under CMV promoter as seperated protein(not as fusion). The Puromycin marker was expressed under Rsv promoter. |
|||
MCF7/Luciferase (puromycin) cells |
|||
S0006049 | Addexbio | One Frozen vial | 750 EUR |
A549 / Luciferase-2A-GFP (Puromycin) stable cell line |
|||
SC043-LG | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in A549 human cancer cell line with Puromycin marker. |
|||
MEF Feeder Cells (Puromycin-resistant) |
|||
CBA-312 | Cell Biolabs | 1 vial | 553.2 EUR |
Description: MEF Feeder Cells are mouse embryonic fibroblasts that allow stem cell culture without LIF. Cells must be mitotically inactivated prior to addition of stem cells. Puromycin resistant. |
|||
A549 / Luciferase (Puromycin) stable cell line |
|||
SC043-Luc | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker. |
|||
PiranhaTM HEK293T GFP/Puromycin Stable Cell Line (>1x10^6 cell/vial) |
|||
PTPD600A-1 | SBI | 1 vial | 1037 EUR |
Luciferase (firefly) and CRE co-expression stable cell line (puromycin) |
|||
SC021-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with Puromycin marker. |
|||
Hela-TetR (Puro) stable cells |
|||
SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
Puromycin |
|||
P097-100MG | TOKU-E | 100 mg | 452.4 EUR |
Puromycin |
|||
P097-25MG | TOKU-E | 25 mg | 154.8 EUR |
Puromycin |
|||
571550 | MedKoo Biosciences | 50.0mg | 450 EUR |
Puromycin |
|||
G264 | ABM | 1.0 ml; 10 mg/ml | 60 EUR |
Description: Extracted from Streptomyces alboniger bacteria, Puromycin is an aminonucleoside antibiotic that inhibits protein synthesis by interfering with the translation process. It specifically inhibits peptidyl transfer on both prokaryotic and eukaryotic ribosomes. The antibiotic inhibits the growth of Gram positive bacteria and various animal and insect cells. Fungi and Gram negative bacteria are resistant to Puromycin due to its low permeability. But in some particular conditions puromycin can be used for E. coli. For more than 30 years, puromycin has been widely used as a basic tool for studying protein synthesis. Now, puromycin hydrochloride is particularly useful for the selection of cell types harbouring plasmids carrying puromycin resistance genes. ;RESISTANCE TO PUROMYCIN; The pac gene encoding a Puromycin N-acetyl-transferase (PAC) has been isolated from a Streptomyces productin strain1,2. It is located in a region of the pur cluster linked to the other genes determining the puromycin biosynthetic pathway. The expression of pac gene confers puromycin resistance to transfected mammalian cells3 expressing it. Under some conditions puromycin could also be used for selection of E. coli strains transformed with plasmids carrying the pac gene. CONDITIONS OF SELECTION Puromycin is poorly active on E. coli but is particularly useful in experiments conducted with mammalian cells. It can be used as an alternative to the Neomycin system for transfection experiments. Mammalian cells The working concentrations of puromycin for mammalian cell lines range from 1 to 10µg/mL. In a starting experiment we recommend to determine optimal concentrations of antibiotic required to kill your host cell line. Puromycin quickly kills eukaryotic cells that do not contain the pac gene. Dying cells detach form the plates allowing easy and early identification of transformant clones. References: 1) VARA J., et al. (1985). Biochemistry. 24: 8074-8081 2) LACALLE R.A., et al. (1989). Gene. 79: 375-380 3) DE LA LUNA S and J. ORTIN. (1992). Methods In Enzymology. 216: 376-385 |
|||
Puromycin |
|||
P097-5MG | TOKU-E | 5 mg | 71.53 EUR |
Description: C22H29N7O5 |
|||
Puromycin |
|||
T19978-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Puromycin |
|||
Puromycin |
|||
T19978-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Puromycin |
|||
Puromycin |
|||
T19978-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Puromycin |
|||
Puromycin |
|||
T19978-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Puromycin |
|||
Puromycin |
|||
T19978-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Puromycin |
|||
Enhanced GFP Lentivirus (Puromycin) |
|||
78639-P | BPS Bioscience | 500 µl x 2 | 835 EUR |
Description: Enhanced green fluorescent protein (eGFP) is a modified (F64L and S65T mutations) version of the native GFP protein isolated from jellyfish (Aequorea victoria), with increased fluorescence and more efficient folding. The Enhanced GFP Lentivirus are replication-incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express eGFP under a CMV promoter. eGFP expression and transduction efficiency can easily be verified and optimized via fluorescence microscopy or flow cytometry. eGFP has an excitation wavelength of 488 nm, an emission wavelength of 509 nm, and extinction coefficient of 55,000 M-1cm-1. |
|||
Hela-GFP stable cells (Blasticidin) |
|||
SC034-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: GFP expression stable cell line in Hela cells with Blasticidin marker. |
|||
Puromycin HCl |
|||
20-abx076662 | Abbexa |
|
|
Puromycin-D3 |
|||
P840327 | Toronto Research Chemicals | 25mg | 3000 EUR |
Puromycin,Powder |
|||
CR028-001 | GenDepot | 100mg | 230.4 EUR |
Puromycin,Powder |
|||
CR028-005 | GenDepot | 500mg | 619.2 EUR |
Puromycin,Powder |
|||
CR028-101 | GenDepot | 1g | 1081.2 EUR |
Luciferase(firefly) Report Cell Line(GFP/Puromycin)-HEK293 |
|||
ABC-RC141D | AcceGen | 1 vial | Ask for price |
Description: Transformed from HEK293 cells, expressing firefly luciferase gene II. Luciferase and GFP was individually co-expressed under CMV promoter, The Puromycin marker was expressed under Rsv promoter. The cell constitutively co-expresses both Luciferase and GFP. |
|||
Hela-rtTA (GFP-Bsd) stable cells |
|||
SC038-GB | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Blasticidin fusion dual marker |
|||
Hela-rtTA (GFP-Puro) stable cells |
|||
SC038-GP | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Puromycin fusion dual marker |
|||
Puromycin-5'-Triphosphate |
|||
B7975-.01 | ApexBio | 10 µl (100 mM) | 300 EUR |
Puromycin-5'-Triphosphate |
|||
B7975-.05 | ApexBio | 50 µl (100 mM) | 1206 EUR |
Puromycin-5'-Triphosphate |
|||
B7975-.1 | ApexBio | 100 µl (100 mM) | 2164.8 EUR |
Puromycin Rabbit mAb |
|||
A23031 | Abclonal | 1000μL | 403 EUR |
STAT3 Reporter (Luc) - HEK293 Cell line (Puromycin) |
|||
79800-P | BPS Bioscience | 2 vials | 3730 EUR |
Description: The STAT3 Reporter (Luc)-HEK293 cell line is designed for monitoring STAT3 signal transduction pathway. It contains a firefly luciferase gene driven by STAT3 response elements located upstream of the minimal TATA promoter. After activation by cytokines and growth factors, endogenous STAT3 binds to the DNA response elements, inducing transcription of the luciferase reporter gene. |
|||
Puromycin Dihydrochloride |
|||
1860-100 | Biovision | each | 326.4 EUR |
Puromycin Dihydrochloride |
|||
1860-1000 | Biovision | each | 1554 EUR |
Puromycin Dihydrochloride |
|||
1860-25 | Biovision | each | 151.2 EUR |
Puromycin Dihydrochloride |
|||
1860-250 | Biovision | each | 548.4 EUR |
Puromycin Dihydrochloride |
|||
1860-500 | Biovision | each | 966 EUR |
Puromycin dihydrochloride |
|||
B7587-5.1 | ApexBio | 10 mM (in 1mL H2O) | 142.8 EUR |
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA. |
|||
Puromycin dihydrochloride |
|||
B7587-50 | ApexBio | 50 mg | 157.2 EUR |
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA. |
|||
Puromycin aminonucleoside |
|||
A3740-250 | ApexBio | 250 mg | 1284 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin aminonucleoside |
|||
A3740-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin aminonucleoside |
|||
A3740-50 | ApexBio | 50 mg | 366 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin Dihydrochloride |
|||
P001-1G | TOKU-E | 1 g | 604.8 EUR |
Puromycin Dihydrochloride |
|||
P001-250MG | TOKU-E | 250 mg | 192 EUR |
Puromycin Dihydrochloride |
|||
P001-500MG | TOKU-E | 500 mg | 342 EUR |
Puromycin Aminonucleoside |
|||
P041-100MG | TOKU-E | 100 mg | 519.6 EUR |
Puromycin Aminonucleoside |
|||
P041-1G | TOKU-E | 1g | 2793.6 EUR |
Puromycin Aminonucleoside |
|||
P041-500MG | TOKU-E | 500 mg | 1636.8 EUR |
Puromycin dihydrochloride |
|||
GA1940-100MG | Glentham Life Sciences | 100 mg | 294 EUR |
Puromycin dihydrochloride |
|||
GA1940-10MG | Glentham Life Sciences | 10 mg | 84 EUR |
Puromycin dihydrochloride |
|||
GA1940-250MG | Glentham Life Sciences | 250 mg | 562.8 EUR |
Puromycin dihydrochloride |
|||
GA1940-25MG | Glentham Life Sciences | 25 mg | 132 EUR |
Puromycin dihydrochloride |
|||
GA1940-500MG | Glentham Life Sciences | 500 mg | 982.8 EUR |
Puromycin aminonucleoside |
|||
HY-15695 | MedChemExpress | 10mM/1mL | 135.6 EUR |
Puromycin (Dihydrochloride) |
|||
HY-B1743A | MedChemExpress | 50mg | 198 EUR |
Puromycin Dihydrochloride |
|||
561474 | MedKoo Biosciences | 50.0mg | 200 EUR |
Puromycin Aminonucleoside |
|||
530551 | MedKoo Biosciences | 50.0mg | 750 EUR |
Puromycin dihydrochloride |
|||
GA1940-10 | Glentham Life Sciences | 10 | 39.4 EUR |
Puromycin dihydrochloride |
|||
GA1940-100 | Glentham Life Sciences | 100 | 137.2 EUR |
Puromycin dihydrochloride |
|||
GA1940-25 | Glentham Life Sciences | 25 | 67.3 EUR |
Puromycin dihydrochloride |
|||
GA1940-250 | Glentham Life Sciences | 250 | 274.2 EUR |
Puromycin dihydrochloride |
|||
GA1940-500 | Glentham Life Sciences | 500 | 491.1 EUR |
Puromycin Dihydrochloride |
|||
41610040-1 | Bio-WORLD | 25 mg | 39.89 EUR |
Puromycin Dihydrochloride |
|||
41610040-2 | Bio-WORLD | 50 mg | 62.77 EUR |
Puromycin Dihydrochloride |
|||
41610040-3 | Bio-WORLD | 100 mg | 86.3 EUR |
Puromycin Dihydrochloride |
|||
41610040-4 | Bio-WORLD | 500 mg | 222.36 EUR |
Puromycin, Dihydrochloride |
|||
A4168-100MG | Biomatik Corporation | 100MG | 154 EUR |
Description: Biotechnology |
|||
Puromycin, Dihydrochloride |
|||
A4168-10MG | Biomatik Corporation | 10MG | 30.8 EUR |
Description: Biotechnology |
|||
Puromycin, Dihydrochloride |
|||
A4168-25MG | Biomatik Corporation | 25MG | 46.2 EUR |
Description: Biotechnology |
|||
Puromycin Dihydrochloride |
|||
P001-100MG | TOKU-E | 100 mg | 60.35 EUR |
Description: C22H29N7O5 • 2 HCl |
|||
Puromycin dihydrochloride |
|||
B7587-20 | ApexBio | 20mg | 70 EUR |
Description: allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene. |
|||
Puromycin aminonucleoside |
|||
T16684-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Puromycin aminonucleoside |
|||
Puromycin aminonucleoside |
|||
T16684-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Puromycin aminonucleoside |
|||
Puromycin aminonucleoside |
|||
T16684-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Puromycin aminonucleoside |
|||
Puromycin aminonucleoside |
|||
T16684-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Puromycin aminonucleoside |
|||
Puromycin aminonucleoside |
|||
T16684-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Puromycin aminonucleoside |
|||
Puromycin dihydrochloride |
|||
T2219-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Puromycin dihydrochloride |
|||
Puromycin dihydrochloride |
|||
T2219-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Puromycin dihydrochloride |
|||
Puromycin dihydrochloride |
|||
T2219-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Puromycin dihydrochloride |
|||
Puromycin dihydrochloride |
|||
T2219-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Puromycin dihydrochloride |
|||
Puromycin dihydrochloride |
|||
T2219-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Puromycin dihydrochloride |
|||
Puromycin Dihydrochloride |
|||
P840320 | Toronto Research Chemicals | 250mg | 211 EUR |
Description: 58-58-2 |
|||
Luciferase-2A-GFP(Puromycin) Report Cell Line-A459 |
|||
ABC-RC131D | AcceGen | 1 vial | Ask for price |
Description: Transformed from huamn lung cancer cell line, A549 by lentiviral system with firefly luciferase gene II and GFP. The Luciferase and GFP was co-expressed under CMV promoter as seperated protein(not as fusion). The Puromycin marker was expressed under Rsv promoter. The cell constitutively co-expresses both firefly Luciferase and GFP. Each cell demonstrates strong GFP fluorescent signal and luciferase assay signal(Note: this is pooled stable ell population, not originated from a single cell colony. Thus you will observe the uneven GFP signal intensity amount cells. |
|||
Hela-RFP stable cells |
|||
SC031-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: RFP expression stable cell line in Hela cells with Puromycin marker. |
|||
Luciferase(Puromycin) Report Cell Line-A459 |
|||
ABC-RC130D | AcceGen | 1 vial | Ask for price |
Description: Transformed from huamn lung cancer cell line, A549 by lentiviral system with firefly luciferase gene. The Luciferase was under modified CMV promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Luciferase(Puromycin) Report Cell Line-MCF7 |
|||
ABC-RC156D | AcceGen | 1 vial | Ask for price |
Description: Transformed from human breast cancer cell line, MCF7 adhesive cell using lentivirus expressing firefly luciferase gene. The Luciferase was expressed under the enhanced EF1a promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Puromycin-D3 Dihydrochloride |
|||
P840322 | Toronto Research Chemicals | 1mg | 265 EUR |
pGL3- U6- sgRNA- PGK- puromycin |
|||
PVT10975 | Lifescience Market | 2 ug | 361.2 EUR |
Puromycin Solution, 10mg/ml , Cell Cultere Tested |
|||
CR026-001 | GenDepot | 10ml | 241.2 EUR |
Luciferase(Puromycin) Report Cell Line-CFPAC-1 |
|||
ABC-RC132D | AcceGen | 1 vial | Ask for price |
Description: Transformed from human human pancreatic cancer cell line, CFPAC-1 adhesive epithelial cell, using lentivirus expressing firefly luciferase 3 gene. The Luciferase was expressed under the enhanced EF1a promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Luciferase(Puromycin) Report Cell Line-Jurkat T |
|||
ABC-RC135D | AcceGen | 1 vial | Ask for price |
Description: Transformed from human Jurkat T lymphocyte suspension cells using lentivirus expressing firefly luciferase gene. The Luciferase was expressed under the enhanced EF1a promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Luciferase(firefly) Report Cell Line(Puromycin)-CRE |
|||
ABC-RC137D | AcceGen | 1 vial | Ask for price |
Description: Transformed from HEK293 cells by lentiviral system with sequence verified firefly luciferase gene II and CRE recombinase. Luciferase and CRE was co-expressed under CMV promoter as seperated protein(not as fusion). The Puromycin marker was expressed under Rsv promoter. The cell constitutively co-expresses both firefly Luciferase and CRE. |
|||
EZSolution? Puromycin Dihydrochloride |
|||
1861-100 | Biovision | each | 366 EUR |
Luciferase(Puromycin) Report Cell Line-NCI-H1299 |
|||
ABC-RC161D | AcceGen | 1 vial | Ask for price |
Description: Transformed from human non-small cell lung carcinoma cell line, NCI-H1299 adhesive cell, using lentivirus expressing firefly luciferase 3 gene. The Luciferase was expressed under the enhanced EF1a promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Luciferase(Puromycin) Report Cell Line-ZR-75-1 |
|||
ABC-RC162D | AcceGen | 1 vial | Ask for price |
Description: Transformed from human breast epithelial cancer cell line, ZR-75-1 adhesive cell using lentivirus expressing firefly luciferase gene. The Luciferase was expressed under the enhanced EF1a promoter. The Puromycin marker was expressed under Rsv promoter. The cell line demonstrates high level of bioluminescence signal via firefly luciferase assay. |
|||
Cas9 Lentivirus (Puromycin Selection) |
|||
78066 | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene._x000D_ Cas9 Lentivirus can be used to generate Cas9 expressing cells in almost any mammalian cell line. Cells stably expressing Cas9 can then be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines._x000D_ The Cas9 Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a Cas9 gene driven by an EF1a promoter, along with a Puromycin selection marker._x000D_ |
|||
Puromycin HCl (Translation inhibitor) |
|||
SIH-248-250MG | Stressmarq | 250 mg | 292.8 EUR |
Description: The substance Puromycin HCl is a translation inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white powder which is May be dissolved in DMSO (50 mg/ml); or water (50 mg/ml). |
|||
Puromycin HCl (Translation inhibitor) |
|||
SIH-248-50MG | Stressmarq | 50 mg | 129.6 EUR |
Description: The substance Puromycin HCl is a translation inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white powder which is May be dissolved in DMSO (50 mg/ml); or water (50 mg/ml). |
|||
Luciferase(firefly) Report Cell Line(Puromycin)-HEK293 |
|||
ABC-RC143D | AcceGen | 1 vial | Ask for price |
Description: Transformed from HEK293 cells, expressing the firefly luciferase gene. Luciferase was expressed under CMV promoter, A Puromycin antibiotic marker was expressed under Rsv promoter. The cell constitutively express Luciferase enzyme. |
|||
Luciferase(Renilla) Report Cell Line(Puromycin)-HEK293 |
|||
ABC-RC148D | AcceGen | 1 vial | Ask for price |
Description: Transformed from HEK293 cells by lentiviral system with sequence verified Renilla Luciferase. Renilla luciferase was expressed under CMV promoter, A Puromycin antibiotic marker was expressed under Rsv promoter. The cell constitutively express Renilla luciferase enzyme. |
|||
Puromycin Aminonucleoside Hydrochloride |
|||
P840321 | Toronto Research Chemicals | 10mg | 57 EUR |
Puromycin Solution, 10mg/mL, Sterile |
|||
10450041-1 | Bio-WORLD | 1 mL | 45.58 EUR |
Puromycin Solution, 10mg/mL, Sterile |
|||
10450041-2 | Bio-WORLD | 5x1 mL | 181.65 EUR |
HeLa Cell RepHR Pooled Cell analysis: 250ug DR-HRGFP, 250ug pSce1, 25ug e-GFP, Puromycinorters to detect DNA Hypomethylating Effectors |
|||
DR3250 | TopoGen | 1 | 2550 EUR |
shRNA-H1 (Neg)-(Puromycin) lentivirus |
|||
H1(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
shRNA-U6 (Neg)-(Puromycin) lentivirus |
|||
U6(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
Renilla Luciferase Lentivirus (Puromycin) |
|||
79565-P | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The Renilla Luciferase (Rluc) Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express Renilla luciferase under a CMV promoter. |
|||
Firefly Luciferase Lentivirus Puromycin |
|||
79692-P | BPS Bioscience | 500 µl x 2 | 875 EUR |
Description: The Firefly Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. This virus constitutively express firefly luciferase under a CMV promoter. |
|||
Puromycin Dihydrochloride, Animal-Free |
|||
19752-22 | NACALAI TESQUE | 25MG | 77 EUR |
Puromycin Dihydrochloride, Animal-Free |
|||
19752-64 | NACALAI TESQUE | 10MG | 32.9 EUR |
HR Pooled Cell analysis: 50ug DR-HRGFP, 50ug pSce1, 25ug e-GFP, Puromycin |
|||
DR3050 | TopoGen | 1 | 2175.6 EUR |
HR Pooled Cell analysis: 1000ug DR-HRGFP, 10000ug pSce1, 25ug e-GFP, Puromycin |
|||
DR31000 | TopoGen | 1 | 3423.6 EUR |
HR Pooled Cell analysis: 500ug DR-HRGFP, 500ug pSce1, 25ug e-GFP, Puromycin |
|||
DR3500 | TopoGen | 1 | 3174 EUR |
Luciferase(firefly) Report Cell Line(RFP/Puromycin)-HEK293 |
|||
ABC-RC145D | AcceGen | 1 vial | Ask for price |
Description: Transformed from HEK293 cells, expressing the firefly luciferase gene. Luciferase and RFP was co-expressed under CMV promoter as individual protein(not as fusion). The Puromycin marker was expressed under Rsv promoter. The cell constitutively express both Luciferase and RFP. |
|||
0.1 G PUROMYCIN DIHYDROCHLORIDE, POWDER |
|||
61-385-RA | CORNING | 0,1 g/pk | 195.6 EUR |
Description: Media Catalog; Cell Culture Reagents |
|||
Luciferase-2A-GFP, Hela stable cells (Neomycin) |
|||
SC032-GN | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
Npepps (GFP-tagged) - Mouse aminopeptidase puromycin sensitive (Npepps) |
|||
MG211183 | Origene Technologies GmbH | 10 µg | Ask for price |
NPEPPS (GFP-tagged) - Human aminopeptidase puromycin sensitive (NPEPPS) |
|||
RG209037 | Origene Technologies GmbH | 10 µg | Ask for price |
Luciferase-2A-GFP, Hela stable cells (Blasticidin) |
|||
SC032-GB | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
HEK293-TRPC3 cell line with RFP and Puromycin dual marker |
|||
SC024-RB | GenTarget | 2 x 106 cell/ml x 1ml | 5280 EUR |
Description: Human TRPC3 ion-channel stable cell line with RFP-Blasticidin dual marker. |
|||
HEK293-KCNN4 cell line with RFP and Puromycin dual marker |
|||
SC025-RB | GenTarget | 2 x 106 cell/ml x 1ml | 5280 EUR |
Description: Human KCNN4 ion-channel stable cell line with RFP-Blasticidin dual marker. |
|||
HEK293-TRPV1 cell line with RFP and Puromycin dual marker |
|||
SC027-RB | GenTarget | 2 x 106 cell/ml x 1ml | 5280 EUR |
Description: Human TRPV1 ion-channel stable cell line with RFP-Blasticidin dual marker. |
|||
HEK293-ATP2B2 cell line with RFP and Puromycin dual marker |
|||
SC026-RB | GenTarget | 2 x 106 cell/ml x 1ml | 5280 EUR |
Description: Human ATP2B2 ion-channel stable cell line with RFP-Blasticidin dual marker. |
|||
Hela-rtTA (RFP-Bsd) stable cells |
|||
SC038-RB | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with RFP-Blasticidin fusion dual marker |
|||
CMV-Luciferase (firefly)-2A-RFP (Puromycin) |
|||
LVP324 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made lentiviral particles expressing firefly luciferase with RFP and Puromycin dual marker, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-APE206Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
|||
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU58900-100ug | Biomatik Corporation | 100ug | 709.8 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU58900-1mg | Biomatik Corporation | 1mg | 3294.7 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU58900-50ug | Biomatik Corporation | 50ug | 522.7 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU55886-100ug | Biomatik Corporation | 100ug | 760.1 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU55886-1mg | Biomatik Corporation | 1mg | 2995.2 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU55886-50ug | Biomatik Corporation | 50ug | 460.8 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
APE206Hu01 | Cloud-Clone | 10ug | 192 EUR |
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
APE206Hu02 | Cloud-Clone | 10ug | 211 EUR |
Firefly Luciferase-eGFP Lentivirus (Puromycin) |
|||
79980-P | BPS Bioscience | 500 µl x 2 | 875 EUR |
Description: The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and eGFP cassette (Luc-P2A-eGFP) driven by a CMV promoter. Both the luciferase and eGFP are coexpressed under the CMV promoter in the transduced cells, allowing greater flexibility for detection of transduced cells. |
|||
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103502 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103503 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103504 | Abbexa |
|
|
Recombinant Puromycin N-acetyltransferase(pac) |
|||
AP74187 | SAB | 1mg | 2826 EUR |
miR-Tuners Set of 3 MCS vectors (puromycin) |
|||
LV102 | ABM | 3 x 10 µg | 750 EUR |
Expression Negative Control Lentivirus (Puromycin) |
|||
79902-P | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_ |
|||
TCR Activator Lentivirus (CMV Promoter/Puromycin) |
|||
79894-CP | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The TCR Activator Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a gene for a membrane-bound, engineered T cell receptor (TCR) activator driven by a CMV promoter or an EF1a promoter. After transduction, the expression of TCR activator can be monitored in the target cells. |
|||
TCR Activator Lentivirus (EF1a Promoter/Puromycin) |
|||
79894-EP | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The TCR Activator Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a gene for a membrane-bound, engineered T cell receptor (TCR) activator driven by a CMV promoter or an EF1a promoter. After transduction, the expression of TCR activator can be monitored in the target cells. |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43529-100ug | Biomatik Corporation | 100ug | 393.8 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43529-1mg | Biomatik Corporation | 1mg | 1747.2 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43529-50ug | Biomatik Corporation | 50ug | 316.8 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43530-100ug | Biomatik Corporation | 100ug | 393.8 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43530-1mg | Biomatik Corporation | 1mg | 1747.2 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43530-50ug | Biomatik Corporation | 50ug | 316.8 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43531-100ug | Biomatik Corporation | 100ug | 492.8 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43531-1mg | Biomatik Corporation | 1mg | 2184 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPU43531-50ug | Biomatik Corporation | 50ug | 396 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPE206Hu01 | Cloud-Clone | 10ug | 128 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPE206Hu02 | Cloud-Clone | 10ug | 128 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
RPE206Mu01 | Cloud-Clone | 10ug | 160 EUR |
Puromycin DiHCl Solution (10 mg/mL in 20 mM HEPES) |
|||
P025-P026-P025-5x1ML | TOKU-E | P025-5 x 1 mL | 148.8 EUR |
Puromycin DiHCl Solution (10 mg/mL in 20 mM HEPES) |
|||
P026-P026-20ML | TOKU-E | P026-20 mL | 337.2 EUR |
Puromycin dihydrochloride from Streptomyces alboniger |
|||
abx082477-25mg | Abbexa | 25 mg | 376.8 EUR |
Puromycin Dihydrochloride from Streptomyces alboniger |
|||
29455-12 | NACALAI TESQUE | 25MG | 77 EUR |
Puromycin Dihydrochloride from Streptomyces alboniger |
|||
29455-54 | NACALAI TESQUE | 10MG | 32.9 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068793 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068794 | Abbexa |
|
|
Mouse Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068795 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
abx670073-01mg | Abbexa | 0.1 mg | 594 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
abx670074-02mg | Abbexa | 0.2 mg | 678 EUR |
Luciferase (firefly), Hela stable cells (Blasticidin) |
|||
SC032-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Luciferase (firefry) expression stable cell line in Hela cells with Blasticidin marker. |
|||
ELISA Kit for Puromycin Sensitive Aminopeptidase (PSA) |
|||
SEE206Hu | Cloud-Clone | 96Т | 700 EUR |
Puromycin Sensitive Aminopeptidase (PSA) Antibody (Biotin) |
|||
20-abx272551 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody (Biotin) |
|||
20-abx273008 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) CLIA Kit |
|||
20-abx494538 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
DLR-PSA-Hu-48T | DL Develop | 48T | 620.4 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Human Puromycin Sensitive Aminopeptidase (PSA) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
DLR-PSA-Hu-96T | DL Develop | 96T | 807.6 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Human Puromycin Sensitive Aminopeptidase (PSA) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
20-abx152869 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKN48093-48T | Biomatik Corporation | 48T | 378.7 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKN48093-5x96T | Biomatik Corporation | 5x96T | 2569.75 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKN48093-96T | Biomatik Corporation | 96T | 541 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKL60136-5x96T | Biomatik Corporation | 5x96T | 3793.35 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKL60136-96T | Biomatik Corporation | 96T | 798.6 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKU06982-48T | Biomatik Corporation | 48T | 555.66 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKU06982-5x96T | Biomatik Corporation | 5x96T | 3770.55 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
EKU06982-96T | Biomatik Corporation | 96T | 793.8 EUR |
Human PSA(Puromycin Sensitive Aminopeptidase) ELISA Kit |
|||
ELK4486-48T | ELK Biotech | 48T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human PSA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human PSA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human PSA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human PSA in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
Human PSA(Puromycin Sensitive Aminopeptidase) ELISA Kit |
|||
ELK4486-96T | ELK Biotech | 96T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human PSA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human PSA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human PSA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human PSA in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
RD-PSA-Hu-48Tests | Reddot Biotech | 48 Tests | 625.2 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
RD-PSA-Hu-96Tests | Reddot Biotech | 96 Tests | 867.6 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
RDR-PSA-Hu-48Tests | Reddot Biotech | 48 Tests | 652.8 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
RDR-PSA-Hu-96Tests | Reddot Biotech | 96 Tests | 907.2 EUR |